General description
46 & 48 kDa
Immunogen
Recombinant human Pax6.
Application
Anti-Pax6 Antibody, clone AD1.5 is an antibody against Pax6 for use in IH & WB.
Research Category
Neuroscience
Research Sub Category
Developmental Neuroscience
Neuronal & Glial Markers
Western blot. The antibody recognizes the 46 and 48 kDa Pax6 proteins.Immunohistochemistry on frozen tissue sections.Optimal working dilutions must be determined by end user.
Biochem/physiol Actions
Recognizes Pax6.
Physical form
Ascites fluid containing no preservatives.
Unpurified
Preparation Note
Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Analysis Note
Control
Embryonic eye tissue
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
This product can not be purchased for resale.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
| biological source | mouse |
| Quality Level | 100 |
| conjugate | unconjugated |
| antibody form | ascites fluid |
| antibody product type | primary antibodies |
| clone | AD1.5, monoclonal |
| species reactivity | zebrafish, rat, human, chicken, mouse |
| manufacturer/tradename | Chemicon® |
| technique(s) | immunohistochemistry: suitable,western blot: suitable |
| isotype | IgG1 |
| NCBI accession no. | NM_000280.2,NM_001604.3 |
| UniProt accession no. | P26367 |
| shipped in | dry ice |
| target post-translational modification | unmodified |
| Gene Information | human ... PAX6(5080) |
